Obesity

Individuals with type 2 diabetes who received semaglutide had lower probability for medical care related to tobacco dependence compared with other antidiabetes medications, the results of a study in the Annals of Internal Medicine showed.

Optometry in the 21st century has moved strongly toward evidence-based medicine, with the American Optometric Association even publishing a 14-step process to assist in the development of an evidence-based practice.

The FDA granted breakthrough device designation for an endoscopic procedure that resurfaces the duodenum lining to allow for weight maintenance after discontinuation of a GLP-1 receptor agonist, according to an industry press release.

Early initiation of a school-based health education intervention limited adiposity marker progression in elementary-aged children in Spain, researchers reported.

A cross-sectional study revealed that increased vitamin A intake may improve depressive symptoms in patients with heart failure.

Obesity accounts for much of the risk for primary hypertension, and a treatment plan that could address both issues could substantially reduce a person’s underlying risk for cardiovascular disease and other complications.

The FDA is warning providers and patients that dosing errors with compounded injectable semaglutide may be leading to adverse events, according to a press release.

There are many important factors primary care providers must consider when prescribing popular anti-obesity medications, according to experts.

Both obesity pharmacotherapy and bariatric surgery offer paths to substantial weight loss for people who struggle with excess weight, and new data suggest there is also an additional bonus benefit for many — a sustained reduction in blood pressure.

Automated appointment scheduling and reminder messages improved receipt of care and various screenings among women with chronic medical conditions and who were pregnant or recently gave birth, results from a randomized study showed.